Characterization of thromboxane receptors in human platelets.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001667:Binding, Competitive; D001792:Blood Platelets / Q000502:physiology*; D055598:Chemical Phenomena; D002621:Chemistry; D000242:Cyclic AMP / Q000097:blood; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011450:Prostaglandin Endoperoxides, Synthetic / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology; D044262:Prostaglandin H2; D011463:Prostaglandins H / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology; D011465:Prostaglandins, Synthetic / Q000494:pharmacology; D011869:Radioligand Assay; D011956:Receptors, Cell Surface / Q000502:physiology*; D011982:Receptors, Prostaglandin / Q000187:drug effects / Q000502:physiology*; D017482:Receptors, Thromboxane; D013329:Structure-Activity Relationship; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology
D001095:Arachidonic Acids; D011450:Prostaglandin Endoperoxides, Synthetic; D011463:Prostaglandins H; D011465:Prostaglandins, Synthetic; D011956:Receptors, Cell Surface; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D016718:Arachidonic Acid; D044262:Prostaglandin H2; D013928:Thromboxane A2; D000244:Adenosine Diphosphate; D000242:Cyclic AMP